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two of the shRNAs. The sequence of shTDP2 should be
AAGCAAAGATGTCTGAATA and the sequence of shCont should be
AATTCTCCGAACGTGTCACGT. The corrected paragraph is given
below, with the altered text underlined:
2.1. Lentivirus
We designed two different shRNAs against mouse Tardbp
(Tdp-43), Fus, and a control shRNA. The targeted sequences were
50-CGATGAACCCATTGAAATA-30 for shRNA/TDP-43-1 (shTDP1);50-AAGCAAAGATGTCTGAATA-30 for shRNA/TDP-43-2 (shTDP2);
50-GCAACAAAGCTACGGACAA-30 for shRNA/FUS1 (shFUS1);
50-GAGTGGAGGTTATGGTCAA-30 for shRNA/FUS2 (shFUS2);
50-GGCTTAAAGTGCAGCTCAA-30 for shRNA/Cugbp1 (shCugbp1);
and 50-AATTCTCCGAACGTGTCACGT-30 for shRNA/control (shCont).
The shRNAs were cloned into a lentiviral shRNA vector
(pLenti-RNAi-X2 puro DEST, w16-1, which was a kind gift from
Dr. Eric Campeau at Resverlogix Corp.). Lentivirus was prepared
in accordance with the protocols detailed by Campeau et al. [25].
The authors apologize for any inconvenience caused and are
pleased to have the opportunity to make this correction.
